Dr. Andrew Muir, MD
Claim this profileEmory Children's Center
Area of expertise
Type 1 Diabetes
Andrew Muir, MD has run 5 trials for Type 1 Diabetes. Some of their research focus areas include:
Primary Biliary Cirrhosis
Andrew Muir, MD has run 3 trials for Primary Biliary Cirrhosis.
Affiliated Hospitals
Emory Children's Center
Duke University Medical Center
Clinical Trials Andrew Muir, MD is currently running
Anticoagulation + Antiplatelet Therapy
for Post-Operative Atrial Fibrillation
The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated coronary artery bypass graft (CABG) surgery. All patients with a qualifying POAF event, who decline randomization, will be offered the option of enrollment in a parallel registry that captures their baseline risk profile and their treatment strategy in terms of anticoagulants or antiplatelets received. These patients will also be asked to fill out a brief decliner survey.
Recruiting
2 awards
Phase 3
2 criteria
Prevention
for Type 1 Diabetes
Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the early metabolic abnormalities in T1DM is steadily increasing. However, information regarding the natural history of T1DM remains incomplete. The TrialNet Natural History Study of the Development of T1DM (Pathway to Prevention Study) has been designed to clarify this picture, and in so doing, will contribute to the development and implementation of studies aimed at prevention of and early treatment in T1DM. Purpose: TrialNet is an international network dedicated to the study, prevention, and early treatment of type 1 diabetes. TrialNet sites are located throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Sweden, Australia, and New Zealand. TrialNet is dedicated to testing new approaches to the prevention of and early intervention for type 1 diabetes. The goal of the TrialNet Natural History Study of the Development of Type 1 Diabetes is to enhance our understanding of the demographic, immunologic, and metabolic characteristics of individuals at risk for developing type 1 diabetes. The Natural History Study will screen relatives of people with type 1 diabetes to identify those at risk for developing the disease. Relatives of people with type 1 diabetes have about a 5% percent chance of being positive for the antibodies associated with diabetes. TrialNet will identify adults and children at risk for developing diabetes by testing for the presence of these antibodies in the blood. A positive antibody test is an early indication that damage to insulin-secreting cells may have begun. If this test is positive, additional testing will be offered to determine the likelihood that a person may develop diabetes. Individuals with antibodies will be offered the opportunity for further testing to determine their risk of developing diabetes over the next 5 years and to receive close monitoring for the development of diabetes.
Recruiting
1 award
N/A
3 criteria
More about Andrew Muir, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Andrew Muir, MD has experience with
- Placebo
- Linerixibat
- Sulfasalazine
- Screening And Monitoring For Type 1 Diabetes Risk
- NNC0361-0041
- Hydroxychloroquine
Breakdown of trials Andrew Muir, MD has run
Type 1 Diabetes
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis
Choledocholithiasis, Cholangitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew Muir, MD specialize in?
Andrew Muir, MD focuses on Type 1 Diabetes and Primary Biliary Cirrhosis. In particular, much of their work with Type 1 Diabetes has involved mIAA positive patients, or patients who are IA-2A positive.
Is Andrew Muir, MD currently recruiting for clinical trials?
Yes, Andrew Muir, MD is currently recruiting for 2 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Andrew Muir, MD has studied deeply?
Yes, Andrew Muir, MD has studied treatments such as Placebo, Linerixibat, Sulfasalazine.
What is the best way to schedule an appointment with Andrew Muir, MD?
Apply for one of the trials that Andrew Muir, MD is conducting.
What is the office address of Andrew Muir, MD?
The office of Andrew Muir, MD is located at: Emory Children's Center, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory Children's Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.